Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM185336![]() (US10011588, Example 158 | US10689373, Example 158 ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10689373 (2020) BindingDB Entry DOI: 10.7270/Q2DR2ZJF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM185275![]() (US10011588, Example 91 | US10689373, Example 91 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10689373 (2020) BindingDB Entry DOI: 10.7270/Q2DR2ZJF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM185265![]() (US10011588, Example 81 | US10689373, Example 81 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10689373 (2020) BindingDB Entry DOI: 10.7270/Q2DR2ZJF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM185325![]() (US10011588, Example 146 | US10689373, Example 146 ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10689373 (2020) BindingDB Entry DOI: 10.7270/Q2DR2ZJF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM185276![]() (US10011588, Example 92 | US10689373, Example 92 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 8 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10689373 (2020) BindingDB Entry DOI: 10.7270/Q2DR2ZJF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM185287![]() (US10011588, Example 103 | US10689373, Example 103 ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 8 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10689373 (2020) BindingDB Entry DOI: 10.7270/Q2DR2ZJF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM185332![]() (US10011588, Example 155 | US10689373, Example 155 ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 8 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10689373 (2020) BindingDB Entry DOI: 10.7270/Q2DR2ZJF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM185271![]() (US10011588, Example 87 | US10689373, Example 87 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 8 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10689373 (2020) BindingDB Entry DOI: 10.7270/Q2DR2ZJF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM185324![]() (US10011588, Example 145 | US10689373, Example 145 ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10689373 (2020) BindingDB Entry DOI: 10.7270/Q2DR2ZJF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM185334![]() (US10011588, Example 156 | US10689373, Example 156 ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10689373 (2020) BindingDB Entry DOI: 10.7270/Q2DR2ZJF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM185313![]() (US10011588, Example 132 | US10689373, Example 132 ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10689373 (2020) BindingDB Entry DOI: 10.7270/Q2DR2ZJF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM185321![]() (US10011588, Example 142 | US10689373, Example 142 ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10689373 (2020) BindingDB Entry DOI: 10.7270/Q2DR2ZJF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM185261![]() (US10011588, Example 77 | US10689373, Example 77 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10689373 (2020) BindingDB Entry DOI: 10.7270/Q2DR2ZJF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM185323![]() (US10011588, Example 144 | US10689373, Example 144 ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 13 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10689373 (2020) BindingDB Entry DOI: 10.7270/Q2DR2ZJF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM185306![]() (US10011588, Example 125 | US10689373, Example 125 ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | MCE PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 14 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10689373 (2020) BindingDB Entry DOI: 10.7270/Q2DR2ZJF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM185304![]() (US10011588, Example 123 | US10689373, Example 123 ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 18 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10689373 (2020) BindingDB Entry DOI: 10.7270/Q2DR2ZJF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM185269![]() (US10011588, Example 85 | US10689373, Example 85 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 18 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10689373 (2020) BindingDB Entry DOI: 10.7270/Q2DR2ZJF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM185262![]() (US10011588, Example 78 | US10689373, Example 78 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 19 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10689373 (2020) BindingDB Entry DOI: 10.7270/Q2DR2ZJF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM185327![]() (US10011588, Example 148 | US10689373, Example 148 ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 19 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10689373 (2020) BindingDB Entry DOI: 10.7270/Q2DR2ZJF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM185279![]() (US10011588, Example 95 | US10689373, Example 95 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 19 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10689373 (2020) BindingDB Entry DOI: 10.7270/Q2DR2ZJF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM185266![]() (US10011588, Example 82 | US10689373, Example 82 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 21 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10689373 (2020) BindingDB Entry DOI: 10.7270/Q2DR2ZJF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM185305![]() (US10011588, Example 124 | US10689373, Example 124 ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 21 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10689373 (2020) BindingDB Entry DOI: 10.7270/Q2DR2ZJF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM185292![]() (US10011588, Example 109 | US10689373, Example 109 ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 21 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10689373 (2020) BindingDB Entry DOI: 10.7270/Q2DR2ZJF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM185301![]() (US10011588, Example 119 | US10689373, Example 119 ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 22 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10689373 (2020) BindingDB Entry DOI: 10.7270/Q2DR2ZJF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM185268![]() (US10011588, Example 84 | US10689373, Example 84 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 22 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10689373 (2020) BindingDB Entry DOI: 10.7270/Q2DR2ZJF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM185326![]() (US10011588, Example 147 | US10689373, Example 147 ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 24 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10689373 (2020) BindingDB Entry DOI: 10.7270/Q2DR2ZJF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM185291![]() (US10011588, Example 108 | US10689373, Example 108 ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 24 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10689373 (2020) BindingDB Entry DOI: 10.7270/Q2DR2ZJF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM185328![]() (US10011588, Example 149 | US10689373, Example 149 ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 25 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10689373 (2020) BindingDB Entry DOI: 10.7270/Q2DR2ZJF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM185337![]() (US10011588, Example 159 | US10689373, Example 159 ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 25 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10689373 (2020) BindingDB Entry DOI: 10.7270/Q2DR2ZJF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM185290![]() (US10011588, Example 107 | US10689373, Example 107 ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 27 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10689373 (2020) BindingDB Entry DOI: 10.7270/Q2DR2ZJF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM185277![]() (US10011588, Example 94 | US10689373, Example 94 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 28 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10689373 (2020) BindingDB Entry DOI: 10.7270/Q2DR2ZJF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM185289![]() (US10011588, Example 106 | US10689373, Example 106 ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 29 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10689373 (2020) BindingDB Entry DOI: 10.7270/Q2DR2ZJF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM185330![]() (US10011588, Example 151 | US10689373, Example 151 ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 29 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10689373 (2020) BindingDB Entry DOI: 10.7270/Q2DR2ZJF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM185338![]() (US10011588, Example 160 | US10689373, Example 160 ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 29 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10689373 (2020) BindingDB Entry DOI: 10.7270/Q2DR2ZJF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM185317![]() (US10011588, Example 138 | US10689373, Example 138 ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 30 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10689373 (2020) BindingDB Entry DOI: 10.7270/Q2DR2ZJF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM185303![]() (US10011588, Example 122 | US10689373, Example 122 ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 32 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10689373 (2020) BindingDB Entry DOI: 10.7270/Q2DR2ZJF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM185318![]() (US10011588, Example 139 | US10689373, Example 139 ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 32 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10689373 (2020) BindingDB Entry DOI: 10.7270/Q2DR2ZJF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM185216![]() (US10011588, Example 32 | US10689373, Example 32 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 32 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10689373 (2020) BindingDB Entry DOI: 10.7270/Q2DR2ZJF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM185309![]() (US10011588, Example 129 | US10689373, Example 129 ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 33 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10689373 (2020) BindingDB Entry DOI: 10.7270/Q2DR2ZJF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM185260![]() (US10011588, Example 76 | US10689373, Example 76 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 33 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10689373 (2020) BindingDB Entry DOI: 10.7270/Q2DR2ZJF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM185316![]() (US10011588, Example 137 | US10689373, Example 137 ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 34 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10689373 (2020) BindingDB Entry DOI: 10.7270/Q2DR2ZJF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM185294![]() (US10011588, Example 111 | US10689373, Example 111 ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 34 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10689373 (2020) BindingDB Entry DOI: 10.7270/Q2DR2ZJF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM185264![]() (US10011588, Example 80 | US10689373, Example 80 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10689373 (2020) BindingDB Entry DOI: 10.7270/Q2DR2ZJF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM185277![]() (US10011588, Example 94 | US10689373, Example 94 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10689373 (2020) BindingDB Entry DOI: 10.7270/Q2DR2ZJF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM185263![]() (US10011588, Example 79 | US10689373, Example 79 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10689373 (2020) BindingDB Entry DOI: 10.7270/Q2DR2ZJF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM185224![]() (US10011588, Example 40 | US10689373, Example 40 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10689373 (2020) BindingDB Entry DOI: 10.7270/Q2DR2ZJF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM185319![]() (US10011588, Example 140 | US10689373, Example 140 ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10689373 (2020) BindingDB Entry DOI: 10.7270/Q2DR2ZJF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM185241![]() (US10011588, Example 57 | US10689373, Example 57 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 38 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10689373 (2020) BindingDB Entry DOI: 10.7270/Q2DR2ZJF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM185312![]() (US10011588, Example 131 | US10689373, Example 131 ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 39 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10689373 (2020) BindingDB Entry DOI: 10.7270/Q2DR2ZJF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM185288![]() (US10689373, Example 105 | US9156829, 105) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 39 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10689373 (2020) BindingDB Entry DOI: 10.7270/Q2DR2ZJF | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 308 total ) | Next | Last >> |